miR-214 and Its Primary Transcript <i>Dnm3os</i> Regulate Fibrosis and Inflammation Through RAGE Signaling in Diabetic Kidney Disease

The mechanism of renoprotection as a result of receptor for advanced glycation end products (RAGE) deletion is unclear but seems to involve noncoding (ncRNAs). We investigated the regulation of ncRNAs by RAGE in the context of diabetic kidney disease (DKD), exploring the renal expression of ncRNAs, microRNAs, and fibrotic and inflammatory markers in diabetic RAGE-knockout (KO) and wild-type mice, as well as in mesangial cells (MCs) obtained ex vivo from these mice. Elevated miR-214 levels in diabetic RAGE-KO mice had antifibrotic effects by targeting protein diaphanous homolog 1 (DIAPH1). In contrast, the coexpressed host ncRNA, Dnm3os, had an opposite effect, enhancing fibrosis and inflammation in MCs. We propose a novel regulatory mechanism in DKD involving miR-214 and Dnm3os as negative and positive regulators of fibrosis, respectively, through the RAGE-DIAPH1 axis. Targeting DIAPH1 through miR-214 may represent a novel therapeutic strategy for DKD.

Authors

Institutions

Publication Details

Journal
Diabetes
Published
2025-04-04
DOI
https://doi.org/10.2337/db24-0121
Citations
4
Primary Topic
Advanced Glycation End Products research
Type
article
Field-Weighted Citation Impact
5.27
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

miR-214 and Its Primary Transcript Dnm3os Regulate Fibrosis and Inflammation Through RAGE Signaling in Diabetic Kidney Disease

Elif Ilhan Ekinci, Mark Ziemann, Tomohito Gohda, Adrienne Laskowski et al.
4 citations
Diabetes
Advanced Glycation End Products research
5.27
article

miR-214 and Its Primary Transcript Dnm3os Regulate Fibrosis and Inflammation Through RAGE Signaling in Diabetic Kidney Disease

Elif Ilhan Ekinci, Mark Ziemann, Tomohito Gohda, Adrienne Laskowski, Maki Murakoshi, Phillip Kantharidis, Melinda T. Coughlan, Mark Emmanuel Cooper, Brian G. Drew, Jun Okabe, Yusuke Suzuki, Madhura Bose, Shinji Hagiwara, Aaron McClelland, Karly C. Sourris, Hiroko Sakuma
article en
4 citations

Abstract

The mechanism of renoprotection as a result of receptor for advanced glycation end products (RAGE) deletion is unclear but seems to involve noncoding (ncRNAs). We investigated the regulation of ncRNAs by RAGE in the context of diabetic kidney disease (DKD), exploring the renal expression of ncRNAs, microRNAs, and fibrotic and inflammatory markers in diabetic RAGE-knockout (KO) and wild-type mice, as well as in mesangial cells (MCs) obtained ex vivo from these mice. Elevated miR-214 levels in diabetic RAGE-KO mice had antifibrotic effects by targeting protein diaphanous homolog 1 (DIAPH1). In contrast, the coexpressed host ncRNA, Dnm3os, had an opposite effect, enhancing fibrosis and inflammation in MCs. We propose a novel regulatory mechanism in DKD involving miR-214 and Dnm3os as negative and positive regulators of fibrosis, respectively, through the RAGE-DIAPH1 axis. Targeting DIAPH1 through miR-214 may represent a novel therapeutic strategy for DKD.

DiabetesVol. 74(7)
Baker Heart and Diabetes Institute (AU), The University of Melbourne (AU), Juntendo University (JP), Austin Health (AU), Tsurugi Hospital (JP), Monash University (AU)
Good health and well-being
Openalex Percentile: Top 5%
Advanced Glycation End Products research
5.27
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.